A detailed history of Amg National Trust Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Amg National Trust Bank holds 22,049 shares of ABBV stock, worth $3.97 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
22,049
Previous 27,191 18.91%
Holding current value
$3.97 Million
Previous $4.66 Million 6.63%
% of portfolio
0.12%
Previous 0.13%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$163.84 - $199.33 $842,465 - $1.02 Million
-5,142 Reduced 18.91%
22,049 $4.35 Million
Q2 2024

Jul 25, 2024

BUY
$154.79 - $180.76 $879,981 - $1.03 Million
5,685 Added 26.43%
27,191 $4.66 Million
Q1 2024

May 06, 2024

SELL
$159.82 - $182.1 $54,658 - $62,278
-342 Reduced 1.57%
21,506 $3.92 Million
Q4 2023

Feb 08, 2024

SELL
$137.6 - $154.97 $57,516 - $64,777
-418 Reduced 1.88%
21,848 $3.39 Million
Q3 2023

Nov 08, 2023

SELL
$133.59 - $154.65 $187,026 - $216,510
-1,400 Reduced 5.92%
22,266 $3.32 Million
Q2 2023

Aug 02, 2023

SELL
$132.51 - $164.9 $238,915 - $297,314
-1,803 Reduced 7.08%
23,666 $3.19 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $625,438 - $720,285
4,325 Added 20.45%
25,469 $4.06 Million
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $653,653 - $783,901
-4,726 Reduced 18.27%
21,144 $3.42 Million
Q3 2022

Nov 03, 2022

BUY
$134.21 - $153.93 $995,703 - $1.14 Million
7,419 Added 40.21%
25,870 $3.47 Million
Q2 2022

Aug 05, 2022

SELL
$137.62 - $174.96 $25,322 - $32,192
-184 Reduced 0.99%
18,451 $2.72 Million
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $5,411 - $6,713
-41 Reduced 0.22%
18,635 $3.02 Million
Q4 2021

Feb 04, 2022

SELL
$107.43 - $135.93 $41,360 - $52,333
-385 Reduced 2.02%
18,676 $2.53 Million
Q3 2021

Oct 28, 2021

BUY
$106.4 - $120.78 $54,264 - $61,597
510 Added 2.75%
19,061 $2.06 Million
Q2 2021

Aug 03, 2021

SELL
$105.21 - $117.21 $258,606 - $288,102
-2,458 Reduced 11.7%
18,551 $2.09 Million
Q1 2021

May 11, 2021

SELL
$102.3 - $112.62 $2.33 Million - $2.56 Million
-22,767 Reduced 52.01%
21,009 $2.27 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $2.25 Million - $3.03 Million
27,925 Added 176.17%
43,776 $4.69 Million
Q4 2020

Jan 29, 2021

SELL
$80.49 - $108.67 $3.98 Million - $5.37 Million
-49,395 Reduced 75.71%
15,851 $1.7 Million
Q3 2020

Oct 22, 2020

SELL
$85.91 - $100.83 $1.83 Million - $2.15 Million
-21,305 Reduced 24.62%
65,246 $5.72 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $840,013 - $1.12 Million
11,449 Added 15.24%
86,551 $8.5 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $129,516 - $196,362
-2,008 Reduced 2.6%
75,102 $5.72 Million
Q4 2019

Feb 04, 2020

SELL
$72.13 - $90.25 $190,855 - $238,801
-2,646 Reduced 3.32%
77,110 $6.83 Million
Q3 2019

Nov 05, 2019

SELL
$62.98 - $75.72 $205,755 - $247,377
-3,267 Reduced 3.94%
79,756 $6.04 Million
Q2 2019

Jul 31, 2019

BUY
$65.7 - $83.98 $29,696 - $37,958
452 Added 0.55%
83,023 $0
Q1 2019

Apr 25, 2019

SELL
$77.14 - $90.79 $249,239 - $293,342
-3,231 Reduced 3.77%
82,571 $0
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $92,719 - $114,347
1,191 Added 1.41%
85,802 $7.91 Million
Q3 2018

Oct 24, 2018

BUY
$88.91 - $98.84 $120,028 - $133,434
1,350 Added 1.62%
84,611 $0
Q2 2018

Jul 18, 2018

BUY
$89.78 - $106.23 $95,885 - $113,453
1,068 Added 1.3%
83,261 $0
Q1 2018

Apr 16, 2018

SELL
$92.01 - $123.21 $36,159 - $48,421
-393 Reduced 0.48%
82,193 $0
Q4 2017

Feb 08, 2018

BUY
$89.56 - $98.21 $405,885 - $445,087
4,532 Added 5.81%
82,586 $0
Q3 2017

Nov 02, 2017

BUY
$69.85 - $89.22 $53,155 - $67,896
761 Added 0.98%
78,054 $0
Q2 2017

Aug 10, 2017

BUY
N/A
77,293
77,293 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Amg National Trust Bank Portfolio

Follow Amg National Trust Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amg National Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amg National Trust Bank with notifications on news.